Vista Finance LLC Boosts Position in Addus HomeCare Corporation $ADUS

Vista Finance LLC lifted its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 4.0% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,115 shares of the company’s stock after acquiring an additional 121 shares during the period. Vista Finance LLC’s holdings in Addus HomeCare were worth $359,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Mutual of America Capital Management LLC raised its holdings in shares of Addus HomeCare by 4.8% during the 2nd quarter. Mutual of America Capital Management LLC now owns 60,699 shares of the company’s stock worth $6,992,000 after acquiring an additional 2,801 shares during the period. Huntleigh Advisors Inc. raised its holdings in shares of Addus HomeCare by 5.7% during the 2nd quarter. Huntleigh Advisors Inc. now owns 3,971 shares of the company’s stock worth $457,000 after acquiring an additional 213 shares during the period. Nordea Investment Management AB raised its holdings in shares of Addus HomeCare by 0.3% during the 2nd quarter. Nordea Investment Management AB now owns 36,159 shares of the company’s stock worth $4,131,000 after acquiring an additional 111 shares during the period. Equitable Trust Co. raised its holdings in shares of Addus HomeCare by 58.9% during the 2nd quarter. Equitable Trust Co. now owns 15,727 shares of the company’s stock worth $1,812,000 after acquiring an additional 5,832 shares during the period. Finally, Yousif Capital Management LLC raised its holdings in shares of Addus HomeCare by 1.7% during the 2nd quarter. Yousif Capital Management LLC now owns 6,855 shares of the company’s stock worth $790,000 after acquiring an additional 115 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the transaction, the executive vice president directly owned 56,980 shares of the company’s stock, valued at $6,656,403.60. The trade was a 11.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the transaction, the director directly owned 5,067 shares of the company’s stock, valued at approximately $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,310 shares of company stock valued at $3,958,375 in the last three months. 4.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Barclays lifted their price target on Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a report on Tuesday, August 19th. TD Cowen boosted their price objective on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Stephens restated an “overweight” rating and issued a $140.00 price objective on shares of Addus HomeCare in a report on Wednesday, September 3rd. Finally, Wall Street Zen upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Sunday, June 29th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average target price of $137.50.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $118.31 on Friday. The company has a market cap of $2.18 billion, a P/E ratio of 26.12, a P/E/G ratio of 1.80 and a beta of 0.86. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a 50-day moving average of $114.10 and a two-hundred day moving average of $110.59. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.04. The company had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare’s revenue was up 21.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.35 EPS. As a group, analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.